MESSA, LORENZO

MESSA, LORENZO  

Dipartimento di Medicina Molecolare - DMM  

Risultati 1 - 11 di 11 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autore(i) Rivista Serie Titolo libro
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 2016 PARISI, SAVERIOLOREGIAN, ARIANNAANDREIS, SAMANTHANANNETTI, GIULIOBASSO, MONICADAL BELLO, FEDERICOMESSA, LORENZOPALU', GIORGIO + INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES - -
4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy 2017 REALE, ALBERTOMESSA, LORENZOVITIELLO, ADRIANALOREGIAN, ARIANNAPALU', GIORGIO JOURNAL OF CELLULAR PHYSIOLOGY - -
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 2017 NANNETTI, GIULIOMESSA, LORENZOCELEGATO, MARTAPAGNI, SILVANABASSO, MONICAParisi, Saverio G.PALU', GIORGIOLOREGIAN, ARIANNA JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS - -
Insights into the functionality and druggability of the homodimerization of human papillomavirus E6 oncoprotein 2017 Messa, Lorenzo - - -
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys 2018 Peta, ElektraSinigaglia, AlessandroMasi, GiuliaDi Camillo, BarbaraGrassi, AngelaTrevisan, MartaMessa, LorenzoLoregian, AriannaPalù, GiorgioBarzon, Luisa + ONCOGENE - -
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 2018 Messa, LorenzoCelegato, MartaBertagnin, ChiaraMercorelli, BeatriceNannetti, GiulioPalù, GiorgioLoregian, Arianna SCIENTIFIC REPORTS - -
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 2019 Mercorelli, BeatriceMessa, LorenzoPalù, GiorgioGribaudo, GiorgioLoregian, Arianna + ANTIVIRAL RESEARCH - -
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 2020 Celegato M.Messa L.Mercorelli B.Bertagnin C.Palu G.Loregian A. + CANCER LETTERS - -
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 2021 Messa L.Celegato M.Bertagnin C.Mercorelli B.Alvisi G.Palu G.Loregian A. + CANCERS - -
HPV-induced cancers: preclinical therapeutic advancements 2022 Messa L.Loregian A. EXPERT OPINION ON INVESTIGATIONAL DRUGS - -
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 2022 Celegato M.Messa L.Bertagnin C.Mercorelli B.Loregian A. CANCERS - -